Michael Ward Email & Phone Number

Los Angeles, US

Benevolent Capital, a private equity investment firm based in New York and Los Angeles is focused on creating value by providing necessary capital to strategically chosen companies. Utilizing its own resources and through partnerships with leading institutional investors and sophisticated high net worth contacts, Benevolent Capital invests in profitable.

Van Nuys, California, US

Béziers, Occitanie, FR

Santa Monica, CA, US

Los Angeles, US

Brooklyn, US

Sausalito, California, US

Toronto, CA

New York, New York, US

Vancouver, British Columbia, CA

Milford, CT, US

Oulu, Northern Ostrobothnia, FI

Charleston, South Carolina, US

Served as the President & Chief Executive Officer for AEterna Zentaris (NASDAQ and TSX: AEZS), a pharmaceutical company based in Charleston, S.C., and with operations in Frankfurt, Germany, where I served as Managing Director. I handled getting our sole drug candidate Macrilen approved both by the FDA and EMA and its out-licensing to Strongbridge BioPharma.

Schaumburg, IL, US

• Specialty pharmaceutical company (NASDAQ:SGNT) in North America focusing on developing, manufacturing, and marketing injectable pharmaceutical products sold globally with sales over $325 Million. Sagent sells over 110.
• Worked closely with Board of Directors, advisors and CEO in handling all aspects of legal and regulatory process in auction process for sale of Sagent in an all-cash merger transaction ($736 Million) to Nichi-Iko.
• Handled all aspects of legal and regulatory process in acquisition ($40 Million) by Sagent of five injectable generic products (including Propofol) divested by Teva and Actavis
• Developed and implemented several global compliance programs
• Responsible for handling and training of all compliance (CMS, export controls, FCPA, OFAC, privacy and Sunshine Act) and public company (Sarbanes-Oxley and SEC) filing and governance matters
• Participated in all Board of Directors and committee meetings and prepared all consents, minutes and legal/compliance presentations.

• CDK Global (NYSE:CDK) is the largest global provider of integrated information technology and digital marketing solutions to the automotive retail industry which was spun off from ADP into a separate public company on.
• Developed and implemented global anti-bribery, antitrust/competition, code of business conduct, export controls, OFAC, privacy, social media and TCPA policies and training materials
• Chaired the Anti-Bribery and Policy Governance Committee and co-chaired a global Enterprise Risk Assessment project for an Audit Committee ERM project. Legal committee member for SOX and COSO projects
• Created internal global compliance and privacy reporting system, and quarterly reporting materials to the Audit Committee
• Handled U.S.- EU Safe Harbor self-certification filing
• Handled responses and remediation plans to data breaches under numerous state laws

Lake Zurich, Illinois, US

• ACCO Brands (NYSE:ACCO) is one of the world’s largest suppliers of branded office products (Swingline®, Day-Timer®, At-A-Glance,® Five Star®, Quartet®, Kensington®) with operations in over 100 countries. Associate.
• Developed and implemented global anti-bribery, OFAC, EU and Member State privacy, preservation of legal privileges, and antitrust/competition policies and training for employees, suppliers and other third parties
• Supervised litigation matters in various courts and international panels within North America, Latin America, and the EU, serving as second chair in most US-based litigation
• Developed and implemented global product compliances policies and protocols
• Handled internal investigations, Code of Conduct training and annual certification process (1,500 employees), and hotline-based investigations
• Led antitrust regulatory approvals and certain third party due diligence (U.S., Brazil and Canada) in merger with office products group of MeadWestvaco Corporation valued at over $900 Million

Anaheim, CA, US

• $545 Million consumer-brand computer luggage and accessories company with operations in over 105 countries.Senior Vice President, General Counsel and Corporate SecretaryFirst in-house lawyer for global company.
• Successfully pursued multiple global legal actions, obtaining judgments, restitution, and settlements totaling over $35 Million in embezzlement, indemnity, and trade secret actions
• Assisted in developing, implementing and operating a procurement business in Asia for product sourcing and distribution operations
• Created a legal and compliance department, implementing legal processes, procedures and systems for all global regions covering over 500 employees and approximately 100 suppliers
• Led successful recovery actions for multi-million dollar settlements against two Asian suppliers for indemnity actions
• Handled product recalls ordered by CPSC, Health Canada, RAPEX and Asian organizations

Conshohocken, PA, US

• Formerly Bergen Brunswig Corporation. Fortune 35 company ($145 Billion annual revenue) in the medical device and pharmaceutical distribution and services industry (NYSE:ABC).Vice President-Corporate Development, 2000.
• Developed and managed investment activities, resulting in investment gains in excess of $6 Million, as well as other investment vehicles which led to eight-figure increase in targeted sales
• Managed over 15 alliance relationships with suppliers and customers, and assisted in the initial public offering of Omnicell (NASDAQ:OMCL) President & General Manager, MedNet, MPC Corporation (wholly-owned subsidiary.
• Created and implemented new business model as a mail-order pharmacy serving as the back-end operations for public and private internet pharmacy portal companies
• P&L responsibility for a $6 Million annual budget, with overall supervision of approximately 40 employees Director of Legal Affairs, Senior Counsel, 1991-1998 Reported to Chief Legal Officer and responsible for.

M&A, Securities, and transactional lawyer for premier LA-based health care law firm.

Jd

B.A., History And Economics

Education record